Aldeyra The
Status: Publicly traded
Direct answer
Aldeyra The is publicly traded on NASDAQ under the ticker ALDX.
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is reproxalap, a reactive aldehyde species (RASP) modulator, which is in Phase III clinical trial for the treatment of dry eye disease and allergic conjunctivitis; and ADX-2191, a dihydrofolate reductase inhibitor for the treatment of primary vitreoretinal...
Can you invest in Aldeyra The?
Yes. Aldeyra The is publicly traded on NASDAQ under the ticker ALDX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.